Valiant Organics Ltd

VALIANTORGSpecialty Chemicals
230.25+0.00 (+0.00%)
As on 21 Jan 2026, 08:44 amMarket Closed

Fundamental Score

...

Valiant Organics Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

-0.45%
Poor

Return on Capital Employed

2.97%
Excellent

Operating Profit Margin (5Y)

14.25%
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

33.66x

Market Capitalization

733.49 (Cr)

Industry P/E

29.20x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

150.18%
Poor

YoY Quarterly Sales Growth

-1.85%
Poor

Sales Growth (5Y)

4.25%

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Financial Health

Excellent

Debt to Equity

0.29x
Poor

Interest Coverage

2.47x
Poor

Free Cash Flow (5Y)

-16.61 (Cr)

Ownership Structure

Average

Promoter Holding

37.91%
Poor

FII Holding

0.21%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
37.91%
Promoter Holding
733.49 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of VALIANTORG across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Robust Profit Growth (150.18%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Conservative Debt Levels (D/E: 0.29)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

9 factors identified

Below-Average Return on Equity (-0.45%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (2.97%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Limited Growth History (4.25% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.

Weak Interest Coverage (2.47x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.

Negative Free Cash Flow (₹-16.61 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 0.21%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Very Low ROE

Observation: Poor capital utilization and shareholder returns.

Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Financial Statements

Comprehensive financial data for Valiant Organics Ltd

About VALIANTORG

Business Overview

Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India and internationally. The company offers para chloro phenol; ortho chloro phenol; 2,4 di chloro phenol; 2,4,6 tri chloro phenol; n-isopropyl para chloro aniline; meta chloro aniline; para flouro aniline; 4-flouro-N-isopropylaniline; 2,4-dichlorophenoxyacetic acid; para nitro aniline; ortho chloro para nitro aniline; ortho anisidine; para anisidine; ortho toluidine 5 sulfonic acid; 6 acetyl oapsa; ortho nitro aniline para sulphonic acid; ortho amino phenol; 4B and 2B acid; 2,6 di chloro phenol; and para–amino phenol. It also provides IPPCA, OA/PA acetanilide, OT5SA, ortho nitro anisole, and para nitro anisole. The company's products are primarily used as intermediates in agro chemicals, dyes, pigments, pharmaceuticals, cosmetics, specialty chemicals, polymers, and veterinary drugs. It exports its products to Asia, Europe, and the United States. Valiant Organics Limited was incorporated in 1984 and is headquartered in Mumbai, India.

Company Details

Symbol:VALIANTORG
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Mr. Sathiababu Krishnan Kallada
MD & Executive Director
Mr. Mahek Manoj Chheda
CFO & Whole-Time Director
Mr. Kaustubh Bhalchandra Kulkarni
Company Secretary & Compliance Officer

Corporate Events

Recent
Ex-Dividend Date
2023-02-10

VALIANTORG Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)-0.45%
Return on Capital Employed2.97%
Operating Profit Margin (5Y)14.25%
Debt to Equity Ratio0.29
Interest Coverage Ratio2.47

Growth & Valuation

Sales Growth (5Y)4.25%
Profit Growth (5Y)N/A%
EPS Growth (5Y)N/A%
YoY Quarterly Profit Growth150.18%
YoY Quarterly Sales Growth-1.85%

Frequently Asked Questions

What is the current price of Valiant Organics Ltd (VALIANTORG)?

As of 21 Jan 2026, 08:44 am IST, Valiant Organics Ltd (VALIANTORG) is currently trading at ₹230.25. The stock has a market capitalization of ₹733.49 (Cr).

Is VALIANTORG share price Overvalued or Undervalued?

VALIANTORG is currently trading at a P/E ratio of 33.66x, compared to the industry average of 29.20x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.

What factors affect the Valiant Organics Ltd share price?

Key factors influencing VALIANTORG's price include its quarterly earnings growth (Sales Growth: -1.85%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Valiant Organics Ltd a good stock for long-term investment?

Valiant Organics Ltd shows a 5-year Profit Growth of N/A% and an ROE of -0.45%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.29 before investing.

How does Valiant Organics Ltd compare with its industry peers?

Valiant Organics Ltd competes with major peers in the Specialty Chemicals. Investors should compare VALIANTORG's P/E of 33.66x and ROE of -0.45% against the industry averages to determine its competitive standing.

What is the P/E ratio of VALIANTORG and what does it mean?

VALIANTORG has a P/E ratio of 33.66x compared to the industry average of 29.20x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹34 for every ₹1 of annual earnings.

How is VALIANTORG performing according to Bull Run's analysis?

VALIANTORG has a Bull Run fundamental score of 18/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does VALIANTORG belong to?

VALIANTORG operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Valiant Organics Ltd.

What is Return on Equity (ROE) and why is it important for VALIANTORG?

VALIANTORG has an ROE of -0.45%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Valiant Organics Ltd generates profits from shareholders' equity.

How is VALIANTORG's debt-to-equity ratio and what does it indicate?

VALIANTORG has a debt-to-equity ratio of 0.29, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is VALIANTORG's dividend yield and is it a good dividend stock?

VALIANTORG offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has VALIANTORG grown over the past 5 years?

VALIANTORG has achieved 5-year growth rates of: Sales Growth 4.25%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in VALIANTORG and why does it matter?

Promoters hold 37.91% of VALIANTORG shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is VALIANTORG's market capitalization category?

VALIANTORG has a market capitalization of ₹733 crores, placing it in the Small-cap category.

How volatile is VALIANTORG stock?

VALIANTORG has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for VALIANTORG?

VALIANTORG has a 52-week high of ₹N/A and low of ₹N/A.

What is VALIANTORG's operating profit margin trend?

VALIANTORG has a 5-year average Operating Profit Margin (OPM) of 14.25%, indicating the company's operational efficiency.

How is VALIANTORG's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of -1.85% and YoY Profit Growth of 150.18%.

What is the institutional holding pattern in VALIANTORG?

VALIANTORG has FII holding of 0.21% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.